OraSure Technologies, Inc.
$3.19
▲
0.98%
2026-04-21 08:42:00
www.orasure.com
NMS: OSUR
Explore OraSure Technologies, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$221.2 M
Current Price
$3.19
52W High / Low
$3.82 / $2.08
Stock P/E
—
Book Value
$4.84
Dividend Yield
—
ROCE
-18.75%
ROE
-18.3%
Face Value
—
EPS
$-0.94
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
500
Beta
0.85
Debt / Equity
3.87
Current Ratio
6.58
Quick Ratio
5.8
Forward P/E
-6.3
Price / Sales
1.78
Enterprise Value
$18.53 M
EV / EBITDA
-0.32
EV / Revenue
0.16
Rating
None
Target Price
$5
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Milestone Scientific Inc. | $0.29 | — | $23.33 M | — | -155% | -1.32% | $1.11 / $0.22 | $0.04 |
| 2. | GlucoTrack, Inc. | $0.78 | — | $1.55 M | — | -524.96% | 381.2% | $15.9 / $0.62 | $3.06 |
| 3. | STAAR Surgical Company | $25.53 | — | $1.27 B | — | -11.99% | -21.7% | $30.81 / $15.59 | $6.97 |
| 4. | Avantor, Inc. | $8.5 | — | $5.76 B | — | 5.22% | -9.2% | $16.17 / $7.26 | $8.24 |
| 5. | Regentis Biomaterials Ltd. | $2.96 | — | — | — | -181.68% | 75.07% | $8.35 / $2.8 | $0.92 |
| 6. | Microbot Medical Inc. | $2.3 | — | $154.46 M | — | -18.87% | -32.42% | $4.67 / $1.6 | $1.16 |
| 7. | AptarGroup, Inc. | $125.33 | 21.29 | $8.05 B | 1.47% | 12.5% | 15.1% | $164.28 / $103.23 | $41.56 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 26.76 M | 27.09 M | 31.24 M | 29.93 M | 37.45 M |
| Operating Profit | -16.85 M | -15.71 M | -17.29 M | -18.27 M | -12.42 M |
| Net Profit | -19.29 M | -13.71 M | -19.69 M | -16.04 M | -10.79 M |
| EPS in Rs | -0.28 | -0.2 | -0.28 | -0.23 | -0.16 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 115.02 M | 185.83 M | 405.47 M | 387.48 M |
| Operating Profit | -68.12 M | -23.86 M | 43.41 M | -5.24 M |
| Net Profit | -68.73 M | -19.5 M | 53.66 M | -17.13 M |
| EPS in Rs | -0.99 | -0.28 | 0.78 | -0.25 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 403.17 M | 479.66 M | 482.85 M | 444.18 M |
| Total Liabilities | 62.34 M | 69.32 M | 52.17 M | 79.75 M |
| Equity | 340.83 M | 410.34 M | 430.67 M | 364.43 M |
| Current Assets | 261.91 M | 333.22 M | 386.46 M | 325.19 M |
| Current Liabilities | 39.8 M | 33.48 M | 39.54 M | 69.06 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -49.02 M | 27.37 M | 141.58 M | -47.2 M |
| Investing CF | -6.81 M | -39.03 M | 66.15 M | 21.09 M |
| Financing CF | -16.94 M | -4.18 M | -3.02 M | -3.83 M |
| Free CF | -53.22 M | 23.58 M | 131.28 M | -111.11 M |
| Capex | -4.2 M | -3.8 M | -10.3 M | -63.91 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -54.17% | 4.64% | — | — |
| Earnings Growth % | -136.34% | 413.17% | — | — |
| Profit Margin % | -10.49% | 13.23% | -4.42% | — |
| Operating Margin % | -12.84% | 10.71% | -1.35% | — |
| Gross Margin % | 42.72% | 42.33% | 38.31% | — |
| EBITDA Margin % | -7.29% | 15.87% | 2.66% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.